Amineptine in the treatment of amphetamine withdrawal:
a placebo-controlled, randomised, double-blind study
by
Jittiwutikan J, Srisurapanont M, Jarusuraisin N.
Northern Drug Dependence Treatment Centre, Chiang Mai, Thailand.
J Med Assoc Thai 1997 Sep;80(9):587-92

ABSTRACT

Temporary inability to function without amphetamine and the experience of withdrawal syndrome enhance the tendency for repetitive use. The investigators proposed to examine the therapeutic effects of amineptine, an antidepressant with dopamine reuptake inhibition effect, for the treatment of amphetamine withdrawal. The 14-day study was carried out on a randomised, double-blind, placebo-controlled design. The authors assessed the severity of amphetamine withdrawal syndrome by using two measures and performed both end-point and intent-to-treat analyses. The results showed that amineptine helped relieve a depressed mood within one week and improved the general condition within 2 weeks. In conclusion, amineptine is effective in rapid relief of depressed mood and improves the general condition of patients with amphetamine withdrawal. Since the amphetamine withdrawal may last for several weeks, studies with longer duration should be conducted before incorporating amineptine into the clinical practice a of amphetamine withdrawal treatment.

amphetamines.com
Amineptine and sex
Mesolimbic dopamine
Amineptine and the elderly
Amineptine and smart mice
Amineptine and unipolar depression
Amineptine for amphetamine withdrawal



Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide To
Healthy Mood Boosters For All The Family